商务合作
动脉网APP
可切换为仅中文
DUBLIN, Feb. 13, 2024 /PRNewswire/ -- The 'Hydroxychloroquine Global Market Report 2024' has been added to ResearchAndMarkets.com's offering.
都柏林,2024年2月13日/PRNewswire/——ResearchAndMarkets.com的产品中增加了“2024年羟氯喹全球市场报告”。
The global hydroxychloroquine market has shown a robust increase and is projected to continue its growth trajectory, moving from an impressive $2.07 billion in 2023 to an estimated value of $2.86 billion by 2028, expanding at a compound annual growth rate (CAGR) of 6.6%. This growth is supported by the increasing need for effective malaria treatments and the drug's applications in autoimmune diseases management..
全球羟氯喹市场表现出强劲增长,预计将继续其增长轨迹,从2023年令人印象深刻的20.7亿美元增长到2028年的估计价值28.6亿美元,复合年增长率(CAGR)为6.6%。这种增长得到了对有效疟疾治疗需求的增加以及该药物在自身免疫性疾病管理中的应用的支持。。
The growth can be traced back to the growing global demand for combination therapies and personalized medicine, alongside enhancements in healthcare access and governmental funding initiatives. Hydroxychloroquine's pivotal role in managing malaria, rheumatoid arthritis, lupus, and the exploration of its benefits for COVID-19 treatment, has led to this sizeable market expansion..
这种增长可以追溯到全球对联合疗法和个性化医疗的需求不断增长,以及医疗保健服务和政府资助计划的增强。羟氯喹在控制疟疾、类风湿性关节炎、狼疮以及探索其对新型冠状病毒治疗的益处方面发挥着关键作用,这导致了这一规模巨大的市场扩张。。
The prevalence of autoimmune diseases such as rheumatoid arthritis is anticipated to stimulate market growth further. With the CDC reporting a rising number of arthritis cases in the United States, the anti-inflammatory properties of hydroxychloroquine are more relevant than ever. Key market players are ramping up production to meet the increasing demand and extend the range of product offerings..
类风湿性关节炎等自身免疫性疾病的流行预计将进一步刺激市场增长。随着美国疾病预防控制中心报告的关节炎病例数量不断增加,羟氯喹的抗炎特性比以往任何时候都更具相关性。主要市场参与者正在增加产量,以满足不断增长的需求,并扩大产品供应范围。。
Strategic efforts to expand production capacities are underway, and recent market developments signify a robust push toward meeting the burgeoning global requirements. Market giants are poised to further influence the hydroxychloroquine market, ensuring drug availability reaches new heights to cater to the growing patient population..
扩大生产能力的战略努力正在进行中,最近的市场发展意味着朝着满足日益增长的全球需求的方向迈进了一大步。市场巨头准备进一步影响羟氯喹市场,确保药物供应达到新的高度,以满足不断增长的患者人群。。
Key Market Insights:
主要市场见解:
Anticipated growth is driven by escalating demand for anti-inflammatory treatments and malaria prevention measures.
预期的增长是由抗炎治疗和疟疾预防措施需求不断增加所驱动的。
The report highlights increased investment in hydroxychloroquine production to satisfy augmented global demand.
该报告强调增加对羟氯喹生产的投资,以满足不断增长的全球需求。
North America leads the market share, with the Middle East forecasted to emerge as the fastest-growing region.
北美市场份额领先,预计中东将成为增长最快的地区。
Comprehensive coverage of therapeutic effects, distribution channels, and future market trends are included in the research.
该研究全面涵盖了治疗效果,分销渠道和未来市场趋势。
The hydroxychloroquine market entails detailed research revolving around production, demand, and therapeutic applications. Comprehensive regional analysis and a deep dive into key participants shape the report's extensive evaluation of current and future marketplace scenarios.
羟氯喹市场需要围绕生产,需求和治疗应用进行详细的研究。全面的区域分析和对关键参与者的深入研究形成了该报告对当前和未来市场情景的广泛评估。
Emerging as an invaluable resource for industry stakeholders, the report provides a panoramic view of market dynamics and forecasts, equipping readers with essential data to navigate the hydroxychloroquine market landscape effectively.
作为行业利益相关者的宝贵资源,该报告提供了市场动态和预测的全景图,为读者提供了有效导航羟氯喹市场格局的基本数据。
Companies Profiled
公司简介
Bayer
拜耳
Dr. Reddy's Laboratories Ltd.
Reddy博士实验室有限公司。
Zydus Group
Zydus集团
Ipca Laboratories Ltd.
Ipca实验室有限公司
Wallace Pharma
华莱士制药
Teva Pharmaceuticals Inc.
Teva Pharmaceuticals股份有限公司。
Mylan Pharmaceuticals Inc.
美兰制药股份有限公司。
Novartis AG
诺华
Intas Pharmaceuticals Ltd.
Intas制药有限公司
Lupin Limited
卢平有限公司
Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd.
上海中西三威药业有限公司。
Torrent Pharmaceuticals Ltd.
Torrent制药有限公司。
BSE healthcare
疯牛病医疗保健
Hikma Pharmaceuticals plc
希克马制药有限公司
Sandoz International GmbH
Sandoz International GmbH
Cipla Limited
Cipla有限公司
Shenhua Pharmaceutical Co. Ltd.
神华制药股份有限公司。
Sanofi S.A.
赛诺菲美国。
Macleod Pharmaceuticals Ltd.
麦克劳德制药有限公司。
McW Healthcare
McW Healthcare
Laurus Labs
Laurus实验室
TAJ Pharmaceuticals
泰姬陵制药
Wuhan Wuyao Pharmaceutical Co. Ltd.
武汉五药药业有限公司。
MAAN Medex
COUNTRY Medex
Cinkate Corporation
辛凯特公司
Concordia Healthcare
康科迪亚医疗保健
Pfizer Inc.
辉瑞公司。
Cadila Pharmaceuticals
Cadila Pharmaceuticals
Hetero Drugs Ltd.
Hetero Drugs有限公司。
Jubilant Generics Limited
喜庆仿制药有限公司
Alembic Pharmaceuticals Limited
Alembic制药有限公司
Sun Pharmaceutical Industries Ltd.
太阳制药工业有限公司。
Aurobindo Pharma USA Inc.
Aurobindo Pharma USA公司。
Alkem Laboratories Ltd.
Alkem实验室有限公司
Glenmark Pharmaceuticals Ltd.
格兰马克制药有限公司
Unichem Laboratories Ltd.
Unichem实验室有限公司
Wockhardt Limited
Wockhardt有限公司
Emcure Pharmaceuticals Ltd.
Emcure制药有限公司
Strides Pharma Science Ltd.
大步制药科学有限公司。
Indoco Remedies Ltd.
Indoco补救有限公司。
For more information about this report visit https://www.researchandmarkets.com/r/qsu1ma
有关此报告的更多信息,请访问https://www.researchandmarkets.com/r/qsu1ma
About ResearchAndMarkets.com
关于ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。
Media Contact:
媒体联系人:
Research and MarketsLaura Wood, Senior Manager[email protected]
研究与市场高级经理Slaura Wood[受电子邮件保护]
For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900
对于E.S.T办公时间,请拨打+1-917-300-0470(对于美国)/CAN免费电话+1-800-526-8630(对于GMT办公时间),请拨打+353-1-416-8900
U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
U、 美国传真:646-607-1907传真(美国境外):+353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
徽标:https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
来源研究和市场